Your browser is no longer supported. Please, upgrade your browser.
Settings
USPH [NYSE]
U.S. Physical Therapy, Inc.
Index- P/E43.16 EPS (ttm)2.47 Insider Own1.80% Shs Outstand12.85M Perf Week-3.12%
Market Cap1.38B Forward P/E36.94 EPS next Y2.89 Insider Trans-18.52% Shs Float12.60M Perf Month-10.80%
Income31.80M PEG3.60 EPS next Q0.41 Inst Own- Short Float5.09% Perf Quarter-17.08%
Sales423.00M P/S3.27 EPS this Y1.00% Inst Trans-1.71% Short Ratio8.07 Perf Half Y25.08%
Book/sh21.49 P/B4.97 EPS next Y15.83% ROA5.30% Target Price118.33 Perf Year54.38%
Cash/sh2.54 P/C42.03 EPS next 5Y12.00% ROE12.30% 52W Range64.30 - 143.67 Perf YTD-11.21%
Dividend1.40 P/FCF15.66 EPS past 5Y8.30% ROI17.80% 52W High-25.68% Beta1.46
Dividend %1.31% Quick Ratio0.90 Sales past 5Y5.00% Gross Margin23.30% 52W Low66.05% ATR4.09
Employees2550 Current Ratio0.90 Sales Q/Q-3.80% Oper. Margin15.60% RSI (14)39.52 Volatility3.06% 3.80%
OptionableYes Debt/Eq0.08 EPS Q/Q22.70% Profit Margin7.50% Rel Volume0.71 Prev Close107.22
ShortableYes LT Debt/Eq0.06 EarningsFeb 25 BMO Payout27.10% Avg Volume79.52K Price106.77
Recom3.00 SMA20-4.81% SMA50-12.03% SMA2003.88% Volume56,693 Change-0.42%
Feb-26-21Downgrade Barrington Research Outperform → Mkt Perform
Jun-08-20Reiterated Barrington Research Outperform $84 → $95
Apr-30-20Downgrade Sidoti Buy → Neutral
Mar-11-20Upgrade Sidoti Neutral → Buy $128
Feb-28-20Reiterated Barrington Research Outperform $130 → $120
Nov-08-19Upgrade Barrington Research Mkt Perform → Outperform
Mar-08-19Initiated William Blair Outperform
Nov-03-17Downgrade Barrington Research Outperform → Mkt Perform
Sep-08-17Upgrade Sidoti Neutral → Buy
Jul-03-17Upgrade Barrington Research Mkt Perform → Outperform $68
Mar-17-17Downgrade Barrington Research Outperform → Mkt Perform
Nov-04-16Upgrade Barrington Research Mkt Perform → Outperform $61
Aug-05-16Downgrade Barrington Research Outperform → Mkt Perform
May-06-16Upgrade Barrington Research Mkt Perform → Outperform $58
Mar-01-16Downgrade Jefferies Buy → Hold
Nov-06-15Downgrade Barrington Research Outperform → Mkt Perform
May-06-15Upgrade Barrington Research Mkt Perform → Outperform
Dec-12-13Reiterated Dougherty & Company Buy $35 → $40
Aug-23-13Reiterated Dougherty & Company Buy $30 → $35
Jan-14-13Reiterated Dougherty & Company Buy $34 → $30
Apr-02-21 05:52AM  
Apr-01-21 08:50AM  
Mar-23-21 06:41AM  
Mar-10-21 11:00AM  
Mar-08-21 05:10PM  
Feb-25-21 10:31PM  
09:15AM  
08:30AM  
Feb-20-21 06:30AM  
Feb-18-21 07:40AM  
Feb-01-21 11:17AM  
Jan-21-21 10:00AM  
Jan-20-21 07:47AM  
05:54AM  
Dec-25-20 04:58AM  
Dec-14-20 07:50AM  
Dec-10-20 06:47PM  
Dec-02-20 05:29AM  
Dec-01-20 08:30AM  
Nov-17-20 03:34PM  
Nov-13-20 11:00AM  
Nov-09-20 03:00PM  
11:37AM  
Nov-06-20 12:47PM  
Nov-05-20 09:25AM  
08:00AM  
Oct-13-20 10:55AM  
Oct-09-20 08:30AM  
Oct-01-20 08:00AM  
Sep-22-20 08:00AM  
Sep-17-20 12:45PM  
Sep-02-20 08:16AM  
Aug-06-20 11:15AM  
08:00AM  
Aug-04-20 03:55PM  
Jul-30-20 12:34PM  
Jul-14-20 01:19PM  
11:40AM  
Jul-05-20 06:46PM  
Jun-28-20 10:18PM  
Jun-23-20 02:38PM  
09:47AM  
Jun-12-20 11:40AM  
May-25-20 07:51AM  
May-21-20 06:00PM  
09:55AM  
08:38AM  
08:30AM  
08:30AM  
May-18-20 09:25AM  
May-14-20 12:30PM  
Apr-30-20 12:34PM  
10:00AM  
09:08AM  
Apr-16-20 09:50AM  
Apr-10-20 10:29AM  
Mar-23-20 01:26AM  
Mar-18-20 11:40AM  
Mar-17-20 09:59AM  
Mar-09-20 06:58AM  
Mar-02-20 09:01AM  
Feb-27-20 09:45AM  
08:30AM  
08:00AM  
Feb-20-20 12:31PM  
Feb-12-20 01:10PM  
Feb-11-20 12:00PM  
Feb-10-20 11:23AM  
Jan-21-20 11:00AM  
Jan-17-20 02:34PM  
Dec-19-19 09:45PM  
Dec-17-19 02:03PM  
Nov-26-19 01:37AM  
Nov-22-19 08:44AM  
Nov-14-19 01:00PM  
Nov-08-19 10:00AM  
Nov-07-19 09:25AM  
08:00AM  
Oct-31-19 03:31PM  
10:33AM  
Oct-26-19 01:23PM  
Oct-16-19 11:23AM  
Oct-08-19 10:00AM  
Oct-01-19 09:43AM  
08:30AM  
Sep-23-19 01:00PM  
Sep-10-19 06:04AM  
Sep-02-19 10:16PM  
Aug-26-19 10:00AM  
06:53AM  
Aug-19-19 09:15PM  
Aug-15-19 07:15PM  
Aug-09-19 07:32AM  
Aug-08-19 04:24PM  
10:05AM  
08:30AM  
Aug-01-19 10:33AM  
Jul-26-19 08:19AM  
Jul-08-19 02:00PM  
Jul-03-19 12:20PM  
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2020, it operated 544 outpatient physical therapy clinics in 39 states; and managed 38 physical therapy facilities. The company was founded in 1990 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chapman Harry SDirectorMar 25Buy108.001,000108,00034,000Mar 26 09:57 AM
Chapman Harry SDirectorMar 25Sale107.213,000321,64033,000Mar 26 09:57 AM
Chapman Harry SDirectorMar 22Sale120.821,000120,82036,000Mar 26 09:57 AM
Chapman Harry SDirectorMar 18Sale120.342,000240,68037,000Mar 26 09:57 AM
Chapman Harry SDirectorMar 17Sale118.782,000237,57039,000Mar 26 09:57 AM
KUNTZ EDWARD LDirectorMar 15Sale121.731,600194,7685,600Mar 16 08:56 AM
MCAFEE LAWRANCE WFormer Director, Exec VP, CFOMar 05Sale110.755,000553,7756,582Mar 08 02:43 PM
REEVE GRAHAM D.COOMar 01Sale116.501,200139,8006,496Mar 02 12:05 PM
MCAFEE LAWRANCE WFormer Director, Exec VP, CFOFeb 26Sale119.145,000595,70011,582Mar 01 04:45 PM
READING CHRISTOPHER JChief Executive OfficerDec 04Sale106.676,000640,02070,438Dec 04 04:56 PM
Harris Bernard A JrDirectorNov 27Sale107.005,000535,00017,622Nov 30 10:04 AM
BROOKNER MARK JDirectorNov 16Sale109.372,437266,53516,600Nov 17 08:06 AM
Harris Bernard A JrDirectorNov 13Sale105.015,000525,05022,622Nov 16 04:16 PM
REEVE GRAHAM D.COONov 10Sale104.231,000104,2306,137Nov 13 10:11 AM
McDowell GlennChief Operating OfficerNov 10Sale106.1211,5071,221,12314,469Nov 13 10:10 AM
MCAFEE LAWRANCE WFormer Exec VP, CFONov 09Sale112.222,222249,35316,852Nov 10 03:12 PM
REEVE GRAHAM D.COOAug 12Sale90.211,500135,3155,578Aug 14 02:29 PM
MCAFEE LAWRANCE WChief Financial OfficerAug 10Sale91.414,450406,77419,074Aug 11 07:51 PM
BROOKNER MARK JDirectorJun 05Sale86.981,200104,37618,437Jun 05 05:03 PM
BROOKNER MARK JDirectorJun 04Sale79.2337129,39419,637Jun 05 07:46 AM
BROOKNER MARK JDirectorJun 03Sale79.141,02981,43020,008Jun 05 07:46 AM
BROOKNER MARK JDirectorMay 28Sale78.0781363,47121,037May 29 04:30 PM
REEVE GRAHAM D.COOMay 28Sale78.351,00078,3505,519Jun 01 06:03 PM